These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182 [TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Hingorani M; Calder VL; Buckley RJ; Lightman S Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598 [TBL] [Abstract][Full Text] [Related]
7. Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment. Utine CA; Stern M; Akpek EK Ocul Immunol Inflamm; 2019; 27(7):1184-1193. PubMed ID: 30189151 [TBL] [Abstract][Full Text] [Related]
8. Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis. Bremond-Gignac D; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Leonardi A; Am J Ophthalmol; 2020 Apr; 212():116-126. PubMed ID: 31770513 [TBL] [Abstract][Full Text] [Related]
9. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977 [TBL] [Abstract][Full Text] [Related]
11. Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. Anzaar F; Gallagher MJ; Bhat P; Arif M; Farooqui S; Foster CS Cornea; 2008 Sep; 27(8):884-8. PubMed ID: 18724148 [TBL] [Abstract][Full Text] [Related]
12. Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review. Li J; Luo X; Ke H; Liang L Pediatrics; 2018 Apr; 141(Suppl 5):S470-S474. PubMed ID: 29610174 [TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]
14. Topical cyclosporine A 1 mg/ml for atopic keratoconjunctivitis: Five-year case series of 99 children and young people. Dahlmann-Noor AH; Roberts C; Muthusamy K; Calder V; Hingorani M Acta Ophthalmol; 2023 Mar; 101(2):e197-e204. PubMed ID: 36151755 [TBL] [Abstract][Full Text] [Related]
15. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D; Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775 [TBL] [Abstract][Full Text] [Related]
17. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Tzu JH; Utine CA; Stern ME; Akpek EK Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107 [TBL] [Abstract][Full Text] [Related]
18. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease. Baudouin C; de la Maza MS; Amrane M; Garrigue JS; Ismail D; Figueiredo FC; Leonardi A Eur J Ophthalmol; 2017 Nov; 27(6):678-685. PubMed ID: 28708219 [TBL] [Abstract][Full Text] [Related]
19. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis. Stumpf T; Luqmani N; Sumich P; Cook S; Tole D Cornea; 2006 Dec; 25(10):1147-9. PubMed ID: 17172887 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]. Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]